{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:57:20Z","timestamp":1792814240657,"version":"4.5.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,3,14]],"date-time":"2020-03-14T00:00:00Z","timestamp":1584144000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,14]],"date-time":"2020-03-14T00:00:00Z","timestamp":1584144000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01-NS097800"],"award-info":[{"award-number":["R01-NS097800"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s12035-020-01893-7","type":"journal-article","created":{"date-parts":[[2020,3,14]],"date-time":"2020-03-14T05:02:32Z","timestamp":1584162152000},"page":"2495-2508","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Tissue Plasminogen Activator Promotes TXNIP-NLRP3 Inflammasome Activation after Hyperglycemic Stroke in Mice"],"prefix":"10.1007","volume":"57","author":[{"given":"Saifudeen","family":"Ismael","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanaz","family":"Nasoohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arum","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba A.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9869-1342","authenticated-orcid":false,"given":"Tauheed","family":"Ishrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,14]]},"reference":[{"issue":"9","key":"1893_CR1","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.2337\/db19-0440","volume":"68","author":"G Tsivgoulis","year":"2019","unstructured":"Tsivgoulis G, Katsanos AH, Mavridis D, Lambadiari V, Roffe C, Macleod MJ, Sevcik P, Cappellari M et al (2019) Association of baseline hyperglycemia with outcomes of patients with and without diabetes with acute ischemic stroke treated with intravenous thrombolysis: a propensity score\u2013matched analysis from the SITS-ISTR registry. Diabetes 68(9):1861\u20131869","journal-title":"Diabetes"},{"issue":"10","key":"1893_CR2","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1161\/STROKEAHA.108.514307","volume":"39","author":"M Yong","year":"2008","unstructured":"Yong M, Kaste M (2008) Dynamic of hyperglycemia as a predictor of stroke outcome in the ECASS-II trial. Stroke 39(10):2749\u20132755","journal-title":"Stroke"},{"issue":"4","key":"1893_CR3","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1001\/jama.2019.9346","volume":"322","author":"KC Johnston","year":"2019","unstructured":"Johnston KC, Bruno A, Pauls Q, Hall CE, Barrett KM, Barsan W, Fansler A, Van de Bruinhorst K et al (2019) Intensive vs standard treatment of hyperglycemia and functional outcome in patients with acute ischemic stroke: the SHINE randomized clinical trial. JAMA 322(4):326\u2013335","journal-title":"JAMA"},{"issue":"2","key":"1893_CR4","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/ijs.12045","volume":"9","author":"A Bruno","year":"2014","unstructured":"Bruno A, Durkalski VL, Hall CE, Juneja R, Barsan WG, Janis S, Meurer WJ, Fansler A et al (2014) The stroke hyperglycemia insulin network effort (SHINE) trial protocol: a randomized, blinded, efficacy trial of standard vs. intensive hyperglycemia management in acute stroke. Int J Stroke 9(2):246\u2013251","journal-title":"Int J Stroke"},{"issue":"8","key":"1893_CR5","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.2337\/dc06-0204","volume":"29","author":"L Allport","year":"2006","unstructured":"Allport L, Baird T, Butcher K, MacGregor L, Prosser J, Colman P, Davis S (2006) Frequency and temporal profile of poststroke hyperglycemia using continuous glucose monitoring. Diabetes Care 29(8):1839\u20131844","journal-title":"Diabetes Care"},{"key":"1893_CR6","unstructured":"Furie KL, Ay H (2018) Initial evaluation and management of transient ischemic attacks and minor ischemic stroke. UpToDate Waltham, MA"},{"issue":"10","key":"1893_CR7","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.tins.2015.08.003","volume":"38","author":"BW Chow","year":"2015","unstructured":"Chow BW, Gu C (2015) The molecular constituents of the blood\u2013brain barrier. Trends Neurosci 38(10):598\u2013608","journal-title":"Trends Neurosci"},{"issue":"4","key":"1893_CR8","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.bbrc.2005.11.133","volume":"339","author":"T Kago","year":"2006","unstructured":"Kago T, Takagi N, Date I, Takenaga Y, Takagi K, Takeo S (2006) Cerebral ischemia enhances tyrosine phosphorylation of occludin in brain capillaries. Biochem Biophys Res Commun 339(4):1197\u20131203","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"1893_CR9","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/sj.jcbfm.9600375","volume":"27","author":"Y Yang","year":"2007","unstructured":"Yang Y, Estrada EY, Thompson JF, Liu W, Rosenberg GA (2007) Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab 27(4):697\u2013709","journal-title":"J Cereb Blood Flow Metab"},{"issue":"9","key":"1893_CR10","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/01.WCB.0000137868.50767.E8","volume":"24","author":"J Kaur","year":"2004","unstructured":"Kaur J, Zhao Z, Klein GM, Lo EH, Buchan AM (2004) The neurotoxicity of tissue plasminogen activator? J Cereb Blood Flow Metab 24(9):945\u2013963","journal-title":"J Cereb Blood Flow Metab"},{"key":"1893_CR11","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.neuroscience.2018.02.035","volume":"377","author":"S Zhang","year":"2018","unstructured":"Zhang S, An Q, Wang T, Gao S, Zhou G (2018) Autophagy-and MMP-2\/9-mediated reduction and redistribution of ZO-1 contribute to hyperglycemia-increased blood\u2013brain barrier permeability during early reperfusion in stroke. Neuroscience 377:126\u2013137","journal-title":"Neuroscience"},{"issue":"2","key":"1893_CR12","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.nbd.2012.02.008","volume":"46","author":"GS Kim","year":"2012","unstructured":"Kim GS, Jung JE, Narasimhan P, Sakata H, Chan PH (2012) Induction of thioredoxin-interacting protein is mediated by oxidative stress, calcium, and glucose after brain injury in mice. Neurobiol Dis 46(2):440\u2013449","journal-title":"Neurobiol Dis"},{"issue":"29","key":"1893_CR13","doi-asserted-by":"crossref","first-page":"30369","DOI":"10.1074\/jbc.M400549200","volume":"279","author":"PC Schulze","year":"2004","unstructured":"Schulze PC, Yoshioka J, Takahashi T, He Z, King GL, Lee RT (2004) Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein. J Biol Chem 279(29):30369\u201330374","journal-title":"J Biol Chem"},{"issue":"10","key":"1893_CR14","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/j.celrep.2017.05.041","volume":"19","author":"AN Waldhart","year":"2017","unstructured":"Waldhart AN, Dykstra H, Peck AS, Boguslawski EA, Madaj ZB, Wen J, Veldkamp K, Hollowell M et al (2017) Phosphorylation of TXNIP by AKT mediates acute influx of glucose in response to insulin. Cell Rep 19(10):2005\u20132013","journal-title":"Cell Rep"},{"issue":"6","key":"1893_CR15","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1096\/fj.201700856RRR","volume":"32","author":"T Bedarida","year":"2018","unstructured":"Bedarida T, Domingues A, Baron S, Ferreira C, Vibert F, Cottart C-H, Paul J-L, Escriou V et al (2018) Reduced endothelial thioredoxin-interacting protein protects arteries from damage induced by metabolic stress in vivo. FASEB J 32(6):3108\u20133118","journal-title":"FASEB J"},{"issue":"5","key":"1893_CR16","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1159\/000494787","volume":"50","author":"X Ren","year":"2018","unstructured":"Ren X, Wang N-n, Qi H, Y-y Q, C-h Z, Brown E, Kong H, Kong L (2018) Up-regulation thioredoxin inhibits advanced glycation end products-induced neurodegeneration. Cell Physiol Biochem 50(5):1673\u20131686","journal-title":"Cell Physiol Biochem"},{"issue":"2","key":"1893_CR17","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1007\/s12035-014-8766-x","volume":"51","author":"T Ishrat","year":"2015","unstructured":"Ishrat T, Mohamed IN, Pillai B, Soliman S, Fouda AY, Ergul A, El-Remessy AB, Fagan SC (2015) Thioredoxin-interacting protein: a novel target for neuroprotection in experimental thromboembolic stroke in mice. Mol Neurobiol 51(2):766\u2013778","journal-title":"Mol Neurobiol"},{"key":"1893_CR18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.brainresbull.2017.12.009","volume":"137","author":"Z Guo","year":"2018","unstructured":"Guo Z, Yu S, Chen X, Zheng P, Hu T, Duan Z, Liu X, Liu Q et al (2018) Suppression of NLRP3 attenuates hemorrhagic transformation after delayed rtPA treatment in thromboembolic stroke rats: involvement of neutrophil recruitment. Brain Res Bull 137:229\u2013240","journal-title":"Brain Res Bull"},{"issue":"1","key":"1893_CR19","doi-asserted-by":"crossref","first-page":"5971","DOI":"10.1038\/s41598-018-24350-x","volume":"8","author":"S Ismael","year":"2018","unstructured":"Ismael S, Zhao L, Nasoohi S, Ishrat T (2018) Inhibition of the NLRP3-inflammasome as a potential approach for neuroprotection after stroke. Sci Rep 8(1):5971","journal-title":"Sci Rep"},{"issue":"3","key":"1893_CR20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s12975-015-0391-0","volume":"6","author":"S Hafez","year":"2015","unstructured":"Hafez S, Hoda MN, Guo X, Johnson MH, Fagan SC, Ergul A (2015) Comparative analysis of different methods of ischemia\/reperfusion in hyperglycemic stroke outcomes: interaction with tPA. Transl Stroke Res 6(3):171\u2013180","journal-title":"Transl Stroke Res"},{"issue":"10","key":"1893_CR21","doi-asserted-by":"crossref","first-page":"7900","DOI":"10.1007\/s12035-018-0917-z","volume":"55","author":"S Nasoohi","year":"2018","unstructured":"Nasoohi S, Ismael S, Ishrat T (2018) Thioredoxin-interacting protein (TXNIP) in cerebrovascular and neurodegenerative diseases: regulation and implication. Mol Neurobiol 55(10):7900\u20137920","journal-title":"Mol Neurobiol"},{"issue":"18","key":"1893_CR22","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1089\/ars.2012.4761","volume":"19","author":"MA Abdelsaid","year":"2013","unstructured":"Abdelsaid MA, Matragoon S, El-Remessy AB (2013) Thioredoxin-interacting protein expression is required for VEGF-mediated angiogenic signal in endothelial cells. Antioxid Redox Signal 19(18):2199\u20132212","journal-title":"Antioxid Redox Signal"},{"key":"1893_CR23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.biocel.2017.11.013","volume":"94","author":"J Duan","year":"2018","unstructured":"Duan J, Du C, Shi Y, Liu D, Ma J (2018) Thioredoxin-interacting protein deficiency ameliorates diabetic retinal angiogenesis. Int J Biochem Cell Biol 94:61\u201370","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"1893_CR24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3892\/mmr.2016.5974","volume":"15","author":"HT Zhang","year":"2017","unstructured":"Zhang HT, Zhang P, Gao Y, Li CL, Wang HJ, Chen LC, Feng Y, Li RY et al (2017) Early VEGF inhibition attenuates blood-brain barrier disruption in ischemic rat brains by regulating the expression of MMPs. Mol Med Rep 15(1):57\u201364","journal-title":"Mol Med Rep"},{"issue":"3","key":"1893_CR25","doi-asserted-by":"crossref","first-page":"240","DOI":"10.5551\/jat.RV16006","volume":"24","author":"M Kanazawa","year":"2017","unstructured":"Kanazawa M, Takahashi T, Nishizawa M, Shimohata T (2017) Therapeutic strategies to attenuate hemorrhagic transformation after tissue plasminogen activator treatment for acute ischemic stroke. J Atheroscler Thromb 24(3):240\u2013253","journal-title":"J Atheroscler Thromb"},{"issue":"6","key":"1893_CR26","doi-asserted-by":"publisher","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","volume":"8","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG (2010) Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol 8(6):e1000412. https:\/\/doi.org\/10.1371\/journal.pbio.1000412","journal-title":"PLoS Biol"},{"issue":"4","key":"1893_CR27","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s12975-015-0400-3","volume":"6","author":"DW McBride","year":"2015","unstructured":"McBride DW, Klebe D, Tang J, Zhang JH (2015) Correcting for brain swelling\u2019s effects on infarct volume calculation after middle cerebral artery occlusion in rats. Transl Stroke Res 6(4):323\u2013338","journal-title":"Transl Stroke Res"},{"issue":"3","key":"1893_CR28","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s12975-011-0083-3","volume":"2","author":"MM Elgebaly","year":"2011","unstructured":"Elgebaly MM, Ogbi S, Li W, Mezzetti EM, Prakash R, Johnson MH, Bruno A, Fagan SC et al (2011) Neurovascular injury in acute hyperglycemia and diabetes: a comparative analysis in experimental stroke. Transl Stroke Res 2(3):391\u2013398","journal-title":"Transl Stroke Res"},{"issue":"2","key":"1893_CR29","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1210\/en.2005-0679","volume":"147","author":"O S-i","year":"2006","unstructured":"S-i O, Masutani H, Liu W, Horita H, Wang D, Kizaka-Kondoh S, Yodoi J (2006) Thioredoxin-binding protein-2-like inducible membrane protein is a novel vitamin D3 and peroxisome proliferator-activated receptor (PPAR) \u03b3 ligand target protein that regulates PPAR\u03b3 signaling. Endocrinology 147(2):733\u2013743","journal-title":"Endocrinology"},{"issue":"5","key":"1893_CR30","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.2353\/ajpath.2009.090263","volume":"175","author":"W Qi","year":"2009","unstructured":"Qi W, Chen X, Holian J, Tan CY, Kelly DJ, Pollock CA (2009) Transcription factors Kr\u00fcppel-like factor 6 and peroxisome proliferator-activated receptor-\u03b3 mediate high glucose-induced thioredoxin-interacting protein. Am J Pathol 175(5):1858\u20131867","journal-title":"Am J Pathol"},{"issue":"6","key":"1893_CR31","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1111\/j.1460-9568.2006.05037.x","volume":"24","author":"N Victor","year":"2006","unstructured":"Victor N, Wanderi E, Gamboa J, Zhao X, Aronowski J, Deininger K, Lust W, Landreth G et al (2006) Altered PPAR\u03b3 expression and activation after transient focal ischemia in rats. Eur J Neurosci 24(6):1653\u20131663","journal-title":"Eur J Neurosci"},{"issue":"6","key":"1893_CR32","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/00004647-199906000-00010","volume":"19","author":"S Takizawa","year":"1999","unstructured":"Takizawa S, Fukuyama N, Hirabayashi H, Nakazawa H, Shinohara Y (1999) Dynamics of nitrotyrosine formation and decay in rat brain during focal ischemia-reperfusion. J Cereb Blood Flow Metab 19(6):667\u2013672","journal-title":"J Cereb Blood Flow Metab"},{"key":"1893_CR33","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ejphar.2019.04.021","volume":"854","author":"C Li","year":"2019","unstructured":"Li C, Wang X, Cheng F, Du X, Yan J, Zhai C, Mu J, Wang Q (2019) Geniposide protects against hypoxia\/reperfusion-induced blood-brain barrier impairment by increasing tight junction protein expression and decreasing inflammation, oxidative stress, and apoptosis in an in vitro system. Eur J Pharmacol 854:224\u2013231","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"1893_CR34","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/jcbfm.2009.248","volume":"30","author":"AT Bauer","year":"2010","unstructured":"Bauer AT, B\u00fcrgers HF, Rabie T, Marti HH (2010) Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement. J Cereb Blood Flow Metab 30(4):837\u2013848","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"1893_CR35","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1055\/s-0036-1586229","volume":"43","author":"L Fredriksson","year":"2017","unstructured":"Fredriksson L, Lawrence DA, Medcalf RL (2017) tPA modulation of the blood-brain barrier: a unifying explanation for the pleiotropic effects of tPA in the CNS. Semin Thromb Hemost 43(2):154\u2013168. https:\/\/doi.org\/10.1055\/s-0036-1586229","journal-title":"Semin Thromb Hemost"},{"issue":"4","key":"1893_CR36","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s12975-014-0336-z","volume":"5","author":"S Hafez","year":"2014","unstructured":"Hafez S, Coucha M, Bruno A, Fagan SC, Ergul A (2014) Hyperglycemia, acute ischemic stroke, and thrombolytic therapy. Transl Stroke Res 5(4):442\u2013453. https:\/\/doi.org\/10.1007\/s12975-014-0336-z","journal-title":"Transl Stroke Res"},{"key":"1893_CR37","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.gene.2018.07.063","volume":"677","author":"R Liu","year":"2018","unstructured":"Liu R, Luo Q, You W, Jin M (2018) MicroRNA-106 attenuates hyperglycemia-induced vascular endothelial cell dysfunction by targeting HMGB1. Gene 677:142\u2013148","journal-title":"Gene"},{"issue":"1","key":"1893_CR38","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1167\/iovs.18-25617","volume":"60","author":"W Zhang","year":"2019","unstructured":"Zhang W, Wang Y, Kong Y (2019) Exosomes derived from mesenchymal stem cells modulate miR-126 to ameliorate hyperglycemia-induced retinal inflammation via targeting HMGB1. Invest Ophthalmol Vis Sci 60(1):294\u2013303","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1893_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/8193523","volume":"2018","author":"Li Lu","year":"2018","unstructured":"Lu L, Lu Q, Chen W, Li J, Li C, Zheng Z (2018) Vitamin D3 protects against diabetic retinopathy by inhibiting high-glucose-induced activation of the ROS\/TXNIP\/NLRP3 Inflammasome pathway. J Diabetes Res. https:\/\/doi.org\/10.1155\/2018\/8193523","journal-title":"Journal of Diabetes Research"},{"issue":"2","key":"1893_CR40","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00011-016-1002-6","volume":"66","author":"W Chen","year":"2017","unstructured":"Chen W, Zhao M, Zhao S, Lu Q, Ni L, Zou C, Lu L, Xu X et al (2017) Activation of the TXNIP\/NLRP3 inflammasome pathway contributes to inflammation in diabetic retinopathy: a novel inhibitory effect of minocycline. Inflamm Res 66(2):157\u2013166","journal-title":"Inflamm Res"},{"issue":"6","key":"1893_CR41","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1161\/STROKEAHA.114.004889","volume":"45","author":"NM Robbins","year":"2014","unstructured":"Robbins NM, Swanson RA (2014) Opposing effects of glucose on stroke and reperfusion injury: acidosis, oxidative stress, and energy metabolism. Stroke 45(6):1881\u20131886","journal-title":"Stroke"},{"issue":"7","key":"1893_CR42","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1161\/STROKEAHA.117.017080","volume":"48","author":"JP Desilles","year":"2017","unstructured":"Desilles JP, Syvannarath V, Ollivier V, Journe C, Delbosc S, Ducroux C, Boisseau W, Louedec L et al (2017) Exacerbation of thromboinflammation by hyperglycemia precipitates cerebral infarct growth and hemorrhagic transformation. Stroke 48(7):1932\u20131940. https:\/\/doi.org\/10.1161\/STROKEAHA.117.017080","journal-title":"Stroke"},{"key":"1893_CR43","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fncel.2016.00002","volume":"10","author":"Y Suzuki","year":"2016","unstructured":"Suzuki Y, Nagai N, Umemura K (2016) A review of the mechanisms of blood-brain barrier permeability by tissue-type plasminogen activator treatment for cerebral ischemia. Front Cell Neurosci 10:2. https:\/\/doi.org\/10.3389\/fncel.2016.00002","journal-title":"Front Cell Neurosci"},{"issue":"11\u201312","key":"1893_CR44","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1080\/10715762.2018.1521519","volume":"52","author":"H Chen","year":"2018","unstructured":"Chen H, Chen X, Luo Y, Shen J (2018) Potential molecular targets of peroxynitrite in mediating blood\u2013brain barrier damage and haemorrhagic transformation in acute ischaemic stroke with delayed tissue plasminogen activator treatment. Free Radic Res 52(11\u201312):1220\u20131239","journal-title":"Free Radic Res"},{"issue":"11_suppl_1","key":"1893_CR45","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1161\/01.STR.0000143219.16695.af","volume":"35","author":"X Wang","year":"2004","unstructured":"Wang X, Tsuji K, Lee S-R, Ning M, Furie KL, Buchan AM, Lo EH (2004) Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke. Stroke 35(11_suppl_1):2726\u20132730","journal-title":"Stroke"},{"issue":"4","key":"1893_CR46","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/ana.22538","volume":"70","author":"SJ Won","year":"2011","unstructured":"Won SJ, Tang XN, Suh SW, Yenari MA, Swanson RA (2011) Hyperglycemia promotes tissue plasminogen activator-induced hemorrhage by increasing superoxide production. Ann Neurol 70(4):583\u2013590","journal-title":"Ann Neurol"},{"issue":"12","key":"1893_CR47","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1111\/ejn.12551","volume":"39","author":"W Zuo","year":"2014","unstructured":"Zuo W, Chen J, Zhang S, Tang J, Liu H, Zhang D, Chen N (2014) IMM-H004 prevents toxicity induced by delayed treatment of t PA in a rat model of focal cerebral ischemia involving PKA-and PI 3 K-dependent A kt activation. Eur J Neurosci 39(12):2107\u20132118","journal-title":"Eur J Neurosci"},{"key":"1893_CR48","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.trsl.2019.05.007","volume":"212","author":"QD Ai","year":"2019","unstructured":"Ai Q-D, Chen C, Chu S-F, Zhang Z, Luo Y, Guan F-F, Lin M-Y, Liu D et al (2019) IMM-H004 therapy for permanent focal ischemic cerebral injury via CKLF1\/CCR4-mediated NLRP3 inflammasome activation. Transl Res 212:36\u201353","journal-title":"Translational Research"},{"issue":"6","key":"1893_CR49","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1111\/j.1460-9568.2006.05037.x","volume":"24","author":"NA Victor","year":"2006","unstructured":"Victor NA, Wanderi EW, Gamboa J, Zhao X, Aronowski J, Deininger K, Lust WD, Landreth GE et al (2006) Altered PPARgamma expression and activation after transient focal ischemia in rats. Eur J Neurosci 24(6):1653\u20131663. https:\/\/doi.org\/10.1111\/j.1460-9568.2006.05037.x","journal-title":"Eur J Neurosci"},{"issue":"1","key":"1893_CR50","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12974-015-0360-2","volume":"12","author":"W Chi","year":"2015","unstructured":"Chi W, Chen H, Li F, Zhu Y, Yin W, Zhuo Y (2015) HMGB1 promotes the activation of NLRP3 and caspase-8 inflammasomes via NF-\u03baB pathway in acute glaucoma. J Neuroinflammation 12(1):137","journal-title":"J Neuroinflammation"},{"issue":"3","key":"1893_CR51","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.4049\/jimmunol.0900138","volume":"183","author":"SB Willingham","year":"2009","unstructured":"Willingham SB, Allen IC, Bergstralh DT, Brickey WJ, Huang MT-H, Taxman DJ, Duncan JA, Ting JP-Y (2009) NLRP3 (NALP3, Cryopyrin) facilitates in vivo caspase-1 activation, necrosis, and HMGB1 release via inflammasome-dependent and-independent pathways. J Immunol 183(3):2008\u20132015","journal-title":"J Immunol"},{"issue":"14","key":"1893_CR52","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1096\/fj.07-8770com","volume":"21","author":"K Liu","year":"2007","unstructured":"Liu K, Mori S, Takahashi HK, Tomono Y, Wake H, Kanke T, Sato Y, Hiraga N et al (2007) Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats. FASEB J 21(14):3904\u20133916","journal-title":"FASEB J"},{"issue":"2","key":"1893_CR53","volume":"12","author":"Y Song","year":"2017","unstructured":"Song Y, Jun J-H, Shin E-J, Kwak Y-L, Shin J-S, Shim J-K (2017) Effect of pregabalin administration upon reperfusion in a rat model of hyperglycemic stroke: mechanistic insights associated with high-mobility group box 1. PLoS One 12(2):e0171147","journal-title":"PLoS One"},{"issue":"5","key":"1893_CR54","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1161\/STROKEAHA.110.598334","volume":"42","author":"J Zhang","year":"2011","unstructured":"Zhang J, Takahashi HK, Liu K, Wake H, Liu R, Maruo T, Date I, Yoshino T et al (2011) Anti-high mobility group box-1 monoclonal antibody protects the blood\u2013brain barrier from ischemia-induced disruption in rats. Stroke 42(5):1420\u20131428","journal-title":"Stroke"},{"issue":"1","key":"1893_CR55","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s12974-018-1267-5","volume":"15","author":"M Li","year":"2018","unstructured":"Li M, Chen S, Shi X, Lyu C, Zhang Y, Tan M, Wang C, Zang N et al (2018) Cell permeable HMGB1-binding heptamer peptide ameliorates neurovascular complications associated with thrombolytic therapy in rats with transient ischemic stroke. J Neuroinflammation 15(1):237\u2013249","journal-title":"J Neuroinflammation"},{"issue":"6","key":"1893_CR56","doi-asserted-by":"crossref","first-page":"e01294","DOI":"10.1002\/brb3.1294","volume":"9","author":"X Yi","year":"2019","unstructured":"Yi X, Sui G, Zhou Q, Wang C, Lin J, Chai Z, Zhou J (2019) Variants in matrix metalloproteinase-9 gene are associated with hemorrhagic transformation in acute ischemic stroke patients with atherothrombosis, small artery disease, and cardioembolic stroke. Brain Behav 9(6):e01294","journal-title":"Brain Behav"},{"issue":"5","key":"1893_CR57","doi-asserted-by":"crossref","first-page":"e0198039","DOI":"10.1371\/journal.pone.0198039","volume":"13","author":"Y Shimada","year":"2018","unstructured":"Shimada Y, Shimura H, Tanaka R, Yamashiro K, Koike M, Uchiyama Y, Urabe T, Hattori N (2018) Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator. PLoS One 13(5):e0198039","journal-title":"PLoS One"},{"issue":"12","key":"1893_CR58","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1038\/jcbfm.2009.174","volume":"29","author":"C Zhang","year":"2009","unstructured":"Zhang C, An J, Haile WB, Echeverry R, Strickland DK, Yepes M (2009) Microglial low-density lipoprotein receptor-related protein 1 mediates the effect of tissue-type plasminogen activator on matrix metalloproteinase-9 activity in the ischemic brain. J Cereb Blood Flow Metab 29(12):1946\u20131954","journal-title":"J Cereb Blood Flow Metab"},{"key":"1893_CR59","doi-asserted-by":"crossref","unstructured":"Chen S, Chen Z, Cui J, McCrary ML, Song H, Mobashery S, Chang M, Gu Z (2018) Early abrogation of gelatinase activity extends the time window for tPA thrombolysis after embolic focal cerebral ischemia in mice. eNeuro 5(3)","DOI":"10.1523\/ENEURO.0391-17.2018"},{"issue":"3","key":"1893_CR60","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1161\/STROKEAHA.115.011258","volume":"47","author":"S Hafez","year":"2016","unstructured":"Hafez S, Abdelsaid M, El-Shafey S, Johnson MH, Fagan SC, Ergul A (2016) Matrix metalloprotease 3 exacerbates hemorrhagic transformation and worsens functional outcomes in hyperglycemic stroke. Stroke 47(3):843\u2013851","journal-title":"Stroke"},{"issue":"2","key":"1893_CR61","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11064-017-2411-9","volume":"43","author":"S Hafez","year":"2018","unstructured":"Hafez S, Abdelsaid M, Fagan SC, Ergul A (2018) Peroxynitrite-induced tyrosine nitration contributes to matrix metalloprotease-3 activation: relevance to hyperglycemic ischemic brain injury and tissue plasminogen activator. Neurochem Res 43(2):259\u2013266","journal-title":"Neurochem Res"},{"issue":"4","key":"1893_CR62","doi-asserted-by":"crossref","first-page":"e0195526","DOI":"10.1371\/journal.pone.0195526","volume":"13","author":"V Gerzanich","year":"2018","unstructured":"Gerzanich V, Kwon MS, Woo SK, Ivanov A, Simard JM (2018) SUR1-TRPM4 channel activation and phasic secretion of MMP-9 induced by tPA in brain endothelial cells. PLoS One 13(4):e0195526","journal-title":"PLoS One"},{"issue":"9","key":"1893_CR63","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1167\/iovs.06-1234","volume":"48","author":"M Hollborn","year":"2007","unstructured":"Hollborn M, Stathopoulos C, Steffen A, Wiedemann P, Kohen L, Bringmann A (2007) Positive feedback regulation between MMP-9 and VEGF in human RPE cells. Invest Ophthalmol Vis Sci 48(9):4360\u20134367","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"1893_CR64","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.2337\/db13-0014","volume":"62","author":"M Rodrigues","year":"2013","unstructured":"Rodrigues M, Xin X, Jee K, Babapoor-Farrokhran S, Kashiwabuchi F, Ma T, Bhutto I, Hassan SJ et al (2013) VEGF secreted by hypoxic M\u00fcller cells induces MMP-2 expression and activity in endothelial cells to promote retinal neovascularization in proliferative diabetic retinopathy. Diabetes 62(11):3863\u20133873","journal-title":"Diabetes"},{"issue":"1","key":"1893_CR65","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/jcbfm.2013.163","volume":"34","author":"S Won","year":"2014","unstructured":"Won S, Lee JH, Wali B, Stein DG, Sayeed I (2014) Progesterone attenuates hemorrhagic transformation after delayed tPA treatment in an experimental model of stroke in rats: involvement of the VEGF\u2013MMP pathway. J Cereb Blood Flow Metab 34(1):72\u201380","journal-title":"J Cereb Blood Flow Metab"},{"issue":"10","key":"1893_CR66","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrm.2016.87","volume":"17","author":"M Simons","year":"2016","unstructured":"Simons M, Gordon E, Claesson-Welsh L (2016) Mechanisms and regulation of endothelial VEGF receptor signalling. Nat Rev Mol Cell Biol 17(10):611\u2013625","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"1893_CR67","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1515\/folmed-2017-0029","volume":"59","author":"M Caprnda","year":"2017","unstructured":"Caprnda M, Kubatka P, Saxena S, Valaskova J, Stefanickova J, Kobyliak N, Zulli A, Kruzliak P (2017) The impact of hyperglycemia on VEGF secretion in retinal endothelial cells. Folia Med 59(2):183\u2013189","journal-title":"Folia Med"},{"issue":"9","key":"1893_CR68","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.freeradbiomed.2010.07.016","volume":"49","author":"MR Farrell","year":"2010","unstructured":"Farrell MR, Rogers LK, Liu Y, Welty SE, Tipple TE (2010) Thioredoxin-interacting protein inhibits hypoxia-inducible factor transcriptional activity. Free Radic Biol Med 49(9):1361\u20131367","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"1893_CR69","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2337\/db13-0417","volume":"63","author":"LL Dunn","year":"2014","unstructured":"Dunn LL, Simpson PJ, Prosser HC, Lecce L, Yuen GS, Buckle A, Sieveking DP, Vanags LZ et al (2014) A critical role for thioredoxin-interacting protein in diabetes-related impairment of angiogenesis. Diabetes 63(2):675\u2013687","journal-title":"Diabetes"},{"issue":"4","key":"1893_CR70","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nn.3966","volume":"18","author":"EA Winkler","year":"2015","unstructured":"Winkler EA, Nishida Y, Sagare AP, Rege SV, Bell RD, Perlmutter D, Sengillo JD, Hillman S et al (2015) GLUT1 reductions exacerbate Alzheimer\u2019s disease vasculo-neuronal dysfunction and degeneration. Nat Neurosci 18(4):521\u2013530","journal-title":"Nat Neurosci"},{"issue":"1","key":"1893_CR71","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1750-1326-6-23","volume":"6","author":"PA Muneer","year":"2011","unstructured":"Muneer PA, Alikunju S, Szlachetka AM, Murrin LC, Haorah J (2011) Impairment of brain endothelial glucose transporter by methamphetamine causes blood-brain barrier dysfunction. Mol Neurodegener 6(1):23","journal-title":"Mol Neurodegener"},{"issue":"4","key":"1893_CR72","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.cell.2016.03.033","volume":"165","author":"A Jais","year":"2016","unstructured":"Jais A, Solas M, Backes H, Chaurasia B, Kleinridders A, Theurich S, Mauer J, Steculorum SM et al (2016) Myeloid-cell-derived VEGF maintains brain glucose uptake and limits cognitive impairment in obesity. Cell 165(4):882\u2013895","journal-title":"Cell"},{"key":"1893_CR73","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.molmet.2018.02.004","volume":"11","author":"R Sch\u00fcler","year":"2018","unstructured":"Sch\u00fcler R, Seebeck N, Osterhoff MA, Witte V, Fl\u00f6el A, Busjahn A, Jais A, Br\u00fcning JC et al (2018) VEGF and GLUT1 are highly heritable, inversely correlated and affected by dietary fat intake: consequences for cognitive function in humans. Mol Metab 11:129\u2013136","journal-title":"Mol Metab"},{"issue":"02","key":"1893_CR74","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1055\/s-0038-1653411","volume":"46","author":"C Korninger","year":"1981","unstructured":"Korninger C, Collen D (1981) Studies on the specific fibrinolytic effect of human extrinsic (tissue-type) plasminogen activator in human blood and in various animal species in vitro. Thromb Haemost 46(02):561\u2013565","journal-title":"Thromb Haemost"},{"issue":"Supplement 1","key":"1893_CR75","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2337\/db18-87-OR","volume":"67","author":"LANCE THIELEN","year":"2018","unstructured":"Thielen L, Chen J, Xu G, Jing G, Grayson T, Jo S, Shalev A (2018) Novel small molecule TXNIP inhibitor protects against diabetes. Diabetes 67(Supplement 1). https:\/\/doi.org\/10.2337\/db18-87-OR","journal-title":"Diabetes"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-020-01893-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-020-01893-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-020-01893-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T17:04:20Z","timestamp":1695920660000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-020-01893-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,14]]},"references-count":75,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["1893"],"URL":"https:\/\/doi.org\/10.1007\/s12035-020-01893-7","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,14]]},"assertion":[{"value":"1 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}